TY - JOUR
T1 - Searching for the Genetic Determinants of Peripheral Arterial Disease
T2 - A Review of the Literature and Future Directions
AU - Kellogg, Dean L.
AU - Fisher-Hoch, Susan
AU - McCormick, Joseph B.
AU - Prasad, Anand
N1 - Publisher Copyright:
© 2018 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Peripheral arterial disease (PAD) is a significant but under-recognized disease that is poorly understood despite population-scale genetic studies. To address this morbid disease, clinicians need additional tools to identify, prevent, and treat patients at risk for PAD. Genetic studies of coronary artery disease have yielded promising results for clinical application, which have thus far been lacking in PAD. In this article, we review recent findings, discuss limitations, and propose future directions of genomic study and clinical application. However, despite many studies, we still lack definitive genetic markers for PAD. This can be attributed to the heterogeneity of PAD's pathogenesis and clinical manifestations, as well as inconsistencies in study methodologies, limitations of current genetic assessment techniques, incompletely comprehended molecular pathophysiology, and confounding generalized atherosclerotic risk factors. The goals of this review are to evaluate the limitations of our current genetic knowledge of PAD and to propose approaches to expedite the identification of valuable markers of PAD.
AB - Peripheral arterial disease (PAD) is a significant but under-recognized disease that is poorly understood despite population-scale genetic studies. To address this morbid disease, clinicians need additional tools to identify, prevent, and treat patients at risk for PAD. Genetic studies of coronary artery disease have yielded promising results for clinical application, which have thus far been lacking in PAD. In this article, we review recent findings, discuss limitations, and propose future directions of genomic study and clinical application. However, despite many studies, we still lack definitive genetic markers for PAD. This can be attributed to the heterogeneity of PAD's pathogenesis and clinical manifestations, as well as inconsistencies in study methodologies, limitations of current genetic assessment techniques, incompletely comprehended molecular pathophysiology, and confounding generalized atherosclerotic risk factors. The goals of this review are to evaluate the limitations of our current genetic knowledge of PAD and to propose approaches to expedite the identification of valuable markers of PAD.
KW - candidate gene studies
KW - epigenetics
KW - genome wide association studies
KW - peripheral arterial disease
KW - systems biology
UR - http://www.scopus.com/inward/record.url?scp=85064239758&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064239758&partnerID=8YFLogxK
U2 - 10.1097/CRD.0000000000000231
DO - 10.1097/CRD.0000000000000231
M3 - Review article
C2 - 30946061
AN - SCOPUS:85064239758
SN - 1061-5377
VL - 27
SP - 145
EP - 152
JO - Cardiology in review
JF - Cardiology in review
IS - 3
ER -